Posts on ‘February 6th, 2012’

Phase III study met primary endpoint INDIANAPOLIS, Feb. 7, 2012 (HSMN NewsFeed) — Eli Lilly and Company (NYSE: LLY ) announced today that a Phase III study, published online by European Urology, showed both Cialis® (tadalafil) and tamsulosin sign…
Biopharmaceuticals, Urology
Eli Lilly, Cialis, tadalafil, tamsulosin, benign prostatic hyperplasia

Andrew I. Koven Named Executive Vice President, Chief Administrative Officer and General Counsel Mark A. Glickman Named Senior Vice President, Sales MALVERN, Pa., Feb. 6, 2012 (HSMN NewsFeed) — Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL ), a spe…
Biopharmaceuticals, Personnel
Auxilium Pharmaceuticals

Funding to support continued commercialization of the Hemolung Respiratory Assist System PITTSBURGH–(Healthcare Sales & Marketing Network)–ALung Technologies, Inc., a big developer of advanced respiratory products, announced today that it has clos…
Devices, Venture Capital
ALung Technologies, Hemolung

HOUSTON, Feb. 6, 2012 (HSMN NewsFeed) — TeDan Surgical Innovations, industry leader in surgical access instrumentation, announces the launch of the Phantom Series MIS Anterior Hip Retractor System. TeDan Surgical’s revolutionary hip retractor utilizes a…
Devices, Orthopaedic, Surgery
TeDan Surgical Innovations, Phantom Series, Hip Retractor

New device offers amazing flexibility and large size for acquiring tissue samples NATICK, Mass., Feb. 6, 2012 (HSMN NewsFeed) — Boston Scientific Corporation (NYSE: BSX ) announces the global launch of the Expect 19 Flex Endoscopic Ultrasound Aspir…
Devices
Boston Scientific, Expect 19 Flex, Endoscopic Ultrasound Aspiration Needle